Heterogeneity of triple-negative breast cancer: Histologic subtyping to inform the outcome

Clinical Breast Cancer

Volumn 13, Issue 1, 2013, Pages 31-39

  Montagna, Emilia ^a   Maisonneuve, Patrick ^a   Rotmensz, Nicole ^a   Cancello, Giuseppe ^a   Iorfida, Monica ^a   Balduzzi, Alessandra ^a   Galimberti, Viviana ^a   Veronesi, Paolo ^a,b   Luini, Alberto ^a   Pruneri, Giancarlo ^a,b   Bottiglieri, Luca ^a   Mastropasqua, Mauro G ^a   Goldhirsch, Aron ^a   Viale, Giuseppe ^a,b   Colleoni, Marco ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Adjuvant therapy; Breast cancer; Histologic subtype; Special types; Triple negative

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; APOCRINE CARCINOMA; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; TRIPLE NEGATIVE BREAST CANCER;

EID: 84872336069     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2012.09.002     Document Type: Article

References (33)

1. C.M. Perou, T. Sørlie, M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
2. E.A. Rakha, D.S. Tan, W.D. Foulkes Are triple-negative tumours and basal-like breast cancer synonymous? Breast Cancer Res 9 2007 404 405
3. C.A. Livasy, G. Karaca, R. Nanda Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Mod Pathol 19 2006 264 271 (Pubitemid 43117611)
4. B. Kreike, M. van Kouwenhove, H. Horlings Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas Breast Cancer Res 9 2007 R65
5. E.A. Rakha, S.E. Elsheikh, M.A. Aleskandarany Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes Clin Cancer Res 15 2009 2302 2310
6. S. Irshad, P. Ellis, A. Tutt Molecular heterogeneity of triple-negative breast cancer and its clinical implications Curr Opin Oncol 23 2011 566 577
7. P.P. Rosen, S. Groshen, D.W. Kinne Factors influencing prognosis in node-negative breast carcinoma: Analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up J Clin Oncol 11 1993 2090 2100 (Pubitemid 23332244)
8. D.L. Page Special types of invasive breast cancer, with clinical implications Am J Surg Pathol 27 2003 832 835 (Pubitemid 36617522)
9. M. Colleoni, N. Rotmensz, P. Maisonneuve Outcome of special types of luminal breast cancer Ann Oncol 23 2012 1428 1436
10. U. Veronesi, G. Paganelli, G. Viale A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 2003 546 553 (Pubitemid 36951366)
11. F.A. Tavassoli, P. Devilee Pathology and genetics of tumours of the breast and female genital organs: WHO Classification of Tumour Series 2003 IARC Lyon, France 13 48
12. M. Colleoni, V. Bagnardi, N. Rotmensz A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer Ann Oncol 20 2009 1178 1184
13. C.W. Elston, I.O. Ellis Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis Histopathology 19 1991 403 410 Histopathology 41 2002 151 152 discussion 152
14. J. Hugh, J. Hanson, M.C. Cheang Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial J Clin Oncol 27 2009 1168 1176
15. A. Goldhirsch, W.C. Wood, A.S. Coates Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer Ann Oncol 22 2011 1736 1747
16. A. Goldhirsch, J.N. Ingle, R.D. Gelber Thresholds for therapies: highlights of the St. Gallen International Expert Consensus on the primary therapy of early breast cancer Ann Oncol 20 2009 1319 1329
17. A. Goldhirsch, J.H. Glick, R.D. Gelber Meeting highlights: International consensus panel on the treatment of primary breast cancer J Natl Cancer Inst 90 1998 1601 1608 (Pubitemid 28523434)
18. A. Goldhirsch, J.H. Glick, R.D. Gelber Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer J Clin Oncol 19 2001 3817 3827 (Pubitemid 32880060)
19. P. Francis, J. Crown, A. Di Leo Adjuvant chemotherapy with the sequential or concurrent anthracycline and docetaxel Breast International Group, 02-98 randomized trial J Natl Cancer Inst 100 2008 121 133 (Pubitemid 351480565)
20. M. Colleoni, H.J. Litman, M. Castiglione-Gertsch Duration of adjuvant chemotherapy for breast cancer: A joint analysis of two randomised trials investigating three versus six courses of CMF Br J Cancer 86 2002 1705 1714 (Pubitemid 34712912)
21. B. Weigelt, J.S. Reis-Filho Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 6 2009 718 730
22. B. Weigelt, H.M. Horlings, B. Kreike Refinement of breast cancer classification by molecular characterization of histological special types J Pathol 216 2008 141 150
23. B. Weigelt, B. Kreike, J.S. Reis-Filho Metaplastic breast carcinomas are basal-like breast cancers: A genomic profiling analysis Breast Cancer Res Treat 117 2009 273 280
24. N.C. Turner, J.S. Reis-Filho, A.M. Russell BRCA1 dysfunction in sporadic basal-like breast cancer Oncogene 26 2007 2126 2132 (Pubitemid 46514749)
25. N.C. Turner, J.S. Reis-Filho Basal-like breast cancer and the BRCA1 phenotype Oncogene 25 2006 5846 5853 (Pubitemid 44453440)
26. H.C. Lien, Y.H. Hsiao, Y.S. Lin Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition Oncogene 26 2007 7859 7871 (Pubitemid 350261788)
27. A. Vincent-Salomon, N. Gruel, C. Lucchesi Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity Breast Cancer Res 9 2007 R24
28. F. Bertucci, P. Finetti, N. Cervera Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers Cancer Res 66 2006 4636 4644
29. G. Arpino, G.M. Clark, S. Mohsin Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome Cancer 94 2002 2119 2127 (Pubitemid 34411967)
30. S. Azoulay, M. Laé, P. Fréneaux KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome Mod Pathol 18 2005 1623 1631 (Pubitemid 41670663)
31. H. Takeuchi, K. Tsuji, H. Ueo Clinicopathological features and long-term prognosis of apocrine carcinoma of the breast in Japanese women Breast Cancer Res Treat 88 2004 46 54
32. M. Colleoni, B.F. Cole, G. Viale Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer J Clin Oncol 28 2010 2966 2973
33. G. Viale, N. Rotmensz, P. Maisonneuve Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity Breast Cancer Res Treat 116 2009 317 328